Primary Article
Streptokinase Reperfusion and Early Surgical Revascularization in Patients With Acute Myocardial Infarction
Abstract
During a 21-month period, 150 patients with acute myocardial infarction were offered entry into a study comprising emergency cardiac catheterization, streptokinase infusion for thrombus if present, and coronary artery bypass surgery where appropriate. Forty refused or were excluded, and served as a control group. Approximately 80% of the remainder had coronary thrombosis and obtained benefit as a group from streptokinase reperfusion. Among the 44 who had coronary artery bypass mortality was low except in those having cardiogenic shock at the time of operation. Those without coronary thrombosis appeared to have a better result from early than from delayed operative revascularization. It appears that both streptokinase reperfusion and early coronary artery bypass have a beneficial role in the management of patients with acute myocardial infarction.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.